Diversified Trust
NPCE icon

Diversified Trust’s Neuropace NPCE Stock Holding History

Diversified Trust’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$153K Buy
+11,096
New +$164K ﹤0.01% 987

Other funds holding NPCE

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Diversified Trust's NPCE Position: Q3 2026 in Review

Diversified Trust opened a new position in Neuropace (NPCE) in Q3 2026: 11,096 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #987 among its holdings.

26 funds tracked by Wall St. Rank hold NPCE as of Q3 2026.

  • Diversified Trust held 11,096 shares of Neuropace worth $153K as of Q3 2026.
  • Neuropace was a new Diversified Trust position in Q3 2026.
  • Neuropace made up ﹤0.01% of Diversified Trust's portfolio in Q3 2026, its #987 holding.
  • 26 funds tracked by Wall St. Rank held Neuropace as of Q3 2026.

Based on Diversified Trust's 13F filing for Q3 2026, filed 6 Nov 2026.